Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

7B51

Crystal structure of human CRM1 covalently modified by 2-mercaptoethanol at Cys528

Summary for 7B51
Entry DOI10.2210/pdb7b51/pdb
DescriptorGTP-binding nuclear protein Ran, Exportin-1, GUANOSINE-5'-TRIPHOSPHATE, ... (6 entities in total)
Functional Keywordsexportin, inhibition, nuclear protein
Biological sourceHomo sapiens (Human)
More
Total number of polymer chains2
Total formula weight143374.38
Authors
Shaikhqasem, A.,Ficner, R. (deposition date: 2020-12-03, release date: 2021-03-10, Last modification date: 2024-01-31)
Primary citationShaikhqasem, A.,Schmitt, K.,Valerius, O.,Ficner, R.
Crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP.
Acta Crystallogr.,Sect.F, 77:70-78, 2021
Cited by
PubMed Abstract: CRM1 is a nuclear export receptor that has been intensively targeted over the last decade for the development of antitumor and antiviral drugs. Structural analysis of several inhibitor compounds bound to CRM1 revealed that their mechanism of action relies on the covalent modification of a critical cysteine residue (Cys528 in the human receptor) located in the nuclear export signal-binding cleft. This study presents the crystal structure of human CRM1, covalently modified by 2-mercaptoethanol on Cys528, in complex with RanGTP at 2.58 Å resolution. The results demonstrate that buffer components can interfere with the characterization of cysteine-dependent inhibitor compounds.
PubMed: 33682791
DOI: 10.1107/S2053230X2100203X
PDB entries with the same primary citation
Experimental method
X-RAY DIFFRACTION (2.58 Å)
Structure validation

237423

PDB entries from 2025-06-11

PDB statisticsPDBj update infoContact PDBjnumon